TMCI Stock Analysis
TM
Uncovered
Treace Medical Concepts Inc is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Treace Medical Concepts, Inc. engages in the design, manufacture, and marketing of orthopedic medical devices and biologic solutions. The company is headquartered in Ponte Vedra, Florida and currently employs 423 full-time employees. The company went IPO on 2021-04-23. The Company’s Lapiplasty three-dimensional (3D) Bunion Correction System is a combination of instruments, implants and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. The Lapiplasty System combines its novel surgical approach, the Lapiplasty Procedure, with its procedural instrumentation and single-use implant kits. The firm is also providing Adductoplasty Midfoot Correction System, designed for reproducible correction of the midfoot to provide further support to hallux valgus patients. The Lapiplasty and Adductoplasty Systems are comprised of single-use implant kits and reusable instrument trays. The firm also commercialized new products that address ancillary surgical procedures performed routinely in connection with the Lapiplasty Procedure.